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Abstract
Anorexia nervosa, a severe psychiatric illness, is associated with an intestinal microbial dysbiosis. 
Individual microbial signatures dominate in healthy samples, even over time and under controlled 
conditions, but whether microbial markers of the disorder overcome inter-individual variation 
during the acute stage of illness or renourishment is unknown. We characterized daily changes in 
the intestinal microbiota in three acutely ill patients with anorexia nervosa over the entire course of 
hospital-based renourishment and found significant, patient-specific changes in microbial 
composition and diversity. Even in a state of pathology, individual microbial signatures persist in 
accounting for the majority of intestinal microbial variation.
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Introduction
Anorexia nervosa (AN) is a severe, often life-threatening illness associated with substantial 
medical comorbidity and mortality rates among the highest of any psychiatric disorder 
(Zipfel, Giel, Bulik, Hay, & Schmidt, 2015). Patients with AN often present with 
gastrointestinal (GI) symptoms, including abdominal distention and pain (Mehler & Brown, 
2015), and GI-related effects of renourishment are uncomfortable and distressing—resulting 
in high treatment dropout. Moreover, the evidence base for therapeutic renourishment is 
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weak, in part because of inadequate understanding of underlying biological mechanisms 
(Zipfel et al., 2015).
The intestinal microbiota, which influences gut motility, physiology, and energy regulation 
(Nieuwdorp, Gilijamse, Pai, & Kaplan, 2014), warrants investigation for improving AN 
treatment. AN is associated with intestinal microbial dysbiosis marked by lower microbial 
diversity, taxonomic differences compared with healthy controls, and associations with 
depression and eating disorder psychopathology (Kleiman et al., 2015). We have 
documented changes in the intestinal microbiota in patients with acute AN between hospital 
admission for renourishment and discharge (Kleiman et al., 2015) and now provide granular, 
longitudinal exploration of changes over the course of treatment.
Although individual microbial signatures dominate in healthy samples, even over time and 
under controlled conditions, intestinal microbial dysbiosis is associated with many 
pathologies (Marchesi et al., 2016). Whether effects of treatment (e.g., therapeutic 
renourishment in AN) generate consistent response in the intestinal microbiota, or inter-
individual variation predominates in pathologic microbiotas, is unknown. During 
renourishment, patients with AN are prescribed increasing energy intake levels to achieve a 
target rate of weight gain and often traverse a hypermetabolic period (Schebendach, Golden, 
Jacobson, Hertz, & Shenker, 1997). We know little about changes to the intestinal 
microbiota during this metabolic transition. We therefore, (i) characterized daily changes in 
composition and diversity of the intestinal microbiota in three patients with acute AN during 
hospital-based renourishment; and (ii) identified enteric bacterial groups associated with 
metabolic changes during treatment.
Methods
The study was approved by the Biomedical Institutional Review Board at the University of 
North Carolina at Chapel Hill (UNC). All participants provided written informed consent 
before study participation, and parental permission forms and an age-appropriate assent 
forms were used for participants younger than 18 years.
Study Population
Females (n=3) admitted for inpatient treatment at the UNC Center of Excellence for Eating 
Disorders participated in the study. Patients ages 15 to 64 years meeting DSM-5 criteria for 
AN and presenting at <75% of ideal body weight were recruited from consecutive 
admissions between May and August 2015. Due to possible impact on the intestinal 
microbiota, potential participants were excluded for the following reasons: (i) history of 
gastrointestinal tract surgery (other than appendectomy or cholecystectomy); (ii) history of 
inflammatory bowel diseases, irritable bowel syndrome, celiac disease; (iii) treatment in the 
last two months with antibiotics or steroids; (iv) intentional use of probiotics during the last 
two months (via food or supplement); and/or (v) abuse of laxatives within the last month.
Body Composition and Assessments
Weight and height were assessed at hospital admission using a calibrated digital scale and 
stadiometer. Participants were weighed daily (before breakfast, in a gown) as part of 
Kleiman et al. Page 2













standard treatment on the inpatient eating disorders unit and three times per week (before 
breakfast, without shoes) after stepping down to the partial hospitalization program. Eating 
disorders diagnosis and psychopathology were established via the Eating Disorder 
Examination (Cooper & Fairburn, 1987) and the Structured Clinical Interview for DSM-IV-
TR Axis I Disorders (First, Spitzer, Gibbon, & Williams, 2002) conducted by credentialed 
members of the UNC Center of Excellence for Eating Disorders Assessment Core. Energy 
intake was prescribed by registered dietitians, confirmed via clinical consensus, and in line 
with each participant’s target weight gain trajectory.
Participant metabolic rate was measured at admission and weekly thereafter during 
hospitalized renourishment. Resting energy expenditure (kJ/day) was measured after 
overnight fast, before breakfast with the MedGem indirect calorimeter (Microlife Medical 
Home Solutions, Inc., Golden, CO). The same procedure was repeated one hour post-
breakfast to measure post-prandial resting energy expenditure and calculate diet-induced 
thermogenesis (as percentage increase over resting energy expenditure). Daily physical 
activity expenditure (kJ) was measured using the BODYMEDIA SenseWear armband 
(BodyMedia, Inc., Pittsburgh, PA), worn on the back of the upper left arm for a 24-hour 
period each week (with the exception of bathing or any other continuous contact with 
water). The 24-hour period commenced at the time of resting energy expenditure 
measurement. Active energy expenditure (kJ/day), defined as ≥3.0 metabolic equivalents, 
was also captured by the armband.
Sample Collection, Processing, and Storage
Fecal samples were collected on a daily basis (or as frequently as possible, if less than daily) 
from all participants. Input and output are measured as part of routine treatment on the 
inpatient eating disorders unit, minimizing risk of missing samples, and all samples were 
collected by unit nurses and nursing assistants trained in collection protocols. After stepping 
down to the partial hospitalization program, participants received training in sample 
collection procedures and were provided with at-home collection kits for use on-site or at 
home. All samples were refrigerated after collection and transferred within 24 hours to the 
laboratory, where they were mechanically homogenized with a sterile spatula, aliquoted into 
sterile 2 ml cryotubes, and stored in a −80 °C freezer for future DNA isolation and 
molecular microbiological analysis.
DNA Isolation
Bacterial DNA was isolated from collected samples using a phenol/chloroform extraction 
method combined with physical disruption of bacterial cells and a DNA clean-up kit 
(QIAmp DNA Stool Mini Kit [Qiagen, Valencia, CA]), as previously described (Carroll et 
al., 2011; Carroll, Ringel-Kulka, Siddle, & Ringel, 2012).
Sequencing of 16S rRNA Genes
Bacterial community composition in isolated DNA samples was characterized by 
amplification of the V4 variable region of the 16S rRNA gene by polymerase chain reaction 
(PCR) (forward primer 515, 5'-GA GTG CCA GCM GCC GCG GTA A-3'; reverse primer 
806, 5'-ACG GAC TAC HVG GGT WTC TAA T-3') as previously described (Kleiman et al., 
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2017). Briefly, generation of 16S rRNA sequences consisted of two separate amplifications: 
(1) 95°C for three minutes, then 10 cycles of 95°C for 30 seconds, 50°C for 30 seconds, and 
72°C for 30 seconds, followed by one cycle of 72°C for five minutes using 120 ng of fecal 
DNA as template, 0.4 µM of each 16S V4 primer, and the KAPA2G Robust PCR kit (Kapa 
Biosystems, Wilmington, MA); and (2) 95°C for three minutes, then 22 cycles of 95°C for 
30 seconds, 50°C for 30 seconds, and 72°C for 30 seconds, followed by one cycle of 72°C 
for five minutes using 5 µL of purified PCR product from the first amplification as template, 
1.25 µM of forward and reverse primers that contain Illumina MiSeq adapter sequences with 
a 12-base error-correcting Golay barcode incorporated in the reverse primer, and the KAPA 
HiFi HotStart ReadyMix PCR kit (Werner, Zhou, Caporaso, Knight, & Angenent, 2012). 
Purification of PCR products was carried out after each amplification using the HighPrep 
PCR clean-up kit (MagBio, Lausanne, Switzerland) with a DynaMag-96 side magnet (Life 
Technologies, Carlsbad, CA). 16S rRNA PCR products were then quantified and pooled for 
sequencing. Sequencing was performed on an Illumina MiSeq desktop sequencer (Illumina, 
San Diego, CA) by the High-Throughput Sequencing Facility in the Carolina Center for 
Genome Sciences at the UNC School of Medicine. The BioProject for this study 
(PRJNA382889) is available at https://www.ncbi.nlm.nih.gov/bioproject/PRJNA382889 
with a direct link to the data at the SRA at https://www.ncbi.nlm.nih.gov/sra/?
term=SRP103900 (Wheeler et al., 2007).
Analysis
Classification of 16S rRNA forward sequence reads was performed in duplicate with two 
pipelines: QIIME version 1.5.0, using previously described quality filtering, OTU clustering, 
and taxonomy assignment methods (Caporaso et al., 2010; Kleiman et al., 2017); and 
version 2.10.1 of the RDP classifier with a threshold of a 50% RDP score (Wang, Garrity, 
Tiedje, & Cole, 2007). Both pipelines yielded similar results, with strong separation between 
patients’ samples. Principal coordinates were generated with QIIME, using unweighted 
UniFrac distances (Lozupone & Knight, 2005). Sequences were log-normalized as 
previously described (McCafferty et al., 2013) and diversity of the intestinal microbiota was 
characterized by the Shannon diversity index (Haegeman et al., 2013; Hill, 1973).
Following sequencing, we had 141 samples with sufficient depth (> 10,000 sequences) for 
our downstream analysis and below this depth samples appeared as substantial outliers. The 
mean number of 16S rRNA sequence reads was 69,967 per sample (range: 12,606–198,025 
sequence reads). The RDP classifier reported 185 non-rare taxa (7 phyla, 14 classes, 18 
orders, 39 families, and 107 genera) that were present in at least 25% of our samples.
Linear models were constructed with bacterial taxa (or Shannon diversity index) regressed 
against interaction of time (i.e., length of hospital stay, in days) and patient, inclusive of their 
main effects. Taxa abundance and diversity of bacterial groups were considered at the 
phylum, class, order, family, and genus levels. Additional models that included patient 
metadata (e.g., BMI and energy intake), in addition to a time-patient interaction, were also 
explored. Lastly, linear models were constructed to incorporate metabolic metadata of 
interest (i.e., resting energy expenditure, diet-induced thermogenesis, and active energy 
expenditure) in addition to a time-patient interaction. FDR correction was applied to the 
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number of comparisons per outcome and per taxonomic rank at a threshold of 0.05 
(Benjamini, Drai, Elmer, Kafkafi, & Golani, 2001). P-values from ANOVA models were 
generated by leaving out each term. For example to evaluate the significance of time, an 
ANOVA comparing the full model (time + patient + time*patient) was compared with a 
reduced model of just patient. All analyses were conducted in R; R-scripts are available 
here: https://github.com/mcbtBINF/ANCaseSeries/ (R: A language and environment for 
statistical computing, 2015).
Results
Demographic and clinical characteristics of patients are presented in Table 1 and Figure 1. 
Patients A and B were treated in both inpatient and partial-hospitalization units, while 
Patient C only received inpatient treatment.
Weekly metabolic indicators are presented in Table S1. In all patients, resting energy 
expenditure (REE) increased during treatment, in parallel with BMI and energy intake, and 
consistent with previous reports, diet-induced thermogenesis reached a peak of 158–181% of 
REE in week 2–3 (Schebendach et al., 1997). Total physical activity expenditure and active 
energy expenditure were stable during inpatient treatment but increased substantially in 
Patients A and B in partial-hospitalization, likely reflecting unsanctioned increases in 
physical activity during time off-unit.
In all patients, we observed significant changes in composition and diversity of the intestinal 
microbiota over time at the phylum (n=4), class (n=8), order (n=14), family (n=28) and 
genus (n=68) levels (Figure 1), after FDR correction (Table S2). Of taxa that changed over 
time, magnitude and direction of changes were largely patient-specific (Figure S1). These 
patient-specific patterns included fluctuations in the abundance of both consistently 
detectable taxa (for example, Figures S1 A, B, C) as well as intermittent periods of non-
detection for certain taxa (for example, genus Lactonifactor, Figure S1 D).
As BMI and energy intake were strongly correlated with length of hospitalization and each 
other, similar results were generated by regressing bacterial taxa and diversity against these 
variables (Table S3). High correlation between variables, and reproduction of results across 
models, suggest that increasing model complexity would not yield additional significant 
findings. Moreover, the small number of significant changes in more complex models and 
strong correlation between terms makes meaningful interpretation of differences between 
energy intake, BMI increase, and time difficult. Weekly changes in REE, diet-induced 
thermogenesis, and active energy expenditure were also highly correlated with duration of 
hospitalization and did not generate significant associations with composition or diversity of 
the intestinal microbiota.
Discussion
These results support earlier assertions that individuals do not share a core microbiota, but 
rather house unique microbial communities that experience periods of both high variability 
and relative stability—due to intrinsic and extrinsic factors (David et al., 2014). The Human 
Microbiome Project underscores the diversity of “healthy” microbiotas, unexplained by 
Kleiman et al. Page 5













phenotypic differences. Likewise, inter-individual differences were the predominant source 
of variation in the intestinal microbiota during a controlled feeding study (Wu et al., 2011). 
That this pattern of unique intestinal microbiotas as seen in healthy individuals also occurs 
and persists in a pathologic state associated with microbial dysbiosis is a novel outcome that 
warrants replication in other disorders associated with intestinal microbial dysbiosis. 
Moreover, although these results add to evidence of high inter-individual variability in 
composition of enteric microbial communities, different bacteria can serve similar metabolic 
functions. This could generate similar functional impact from different microbial 
compositions, which has led researchers to posit that individuals may share a “core 
microbiome ” of microbial genes that drive similar functional impact in the host (Turnbaugh 
et al., 2009).
Although a valid design for novel observations, a case series is limited by sample size, lack 
of controls, and in our case, a broad age range of participants. Nonetheless, our results 
contribute to understanding biological changes associated with renourishment in AN. We 
may have been underpowered to detect changes in more complex longitudinal models, but 
this does not rule out possible associations between changes in microbial composition and 
diversity and changes in BMI, dietary intake, or psychopathology. Although patients 
achieved significant weight gain, our results do not support findings of strong associations 
between the intestinal microbiota and BMI (Ley et al., 2005). In measuring metabolic 
changes on a weekly—rather than daily—basis, we may have also been underpowered to 
detect associations with microbial measures, despite evidence supporting a role for the 
intestinal microbiota in metabolic function and dietary energy extraction. As a case series, 
we were also unable to account for any differences across participants that may have been 
due to age. Although our three patients spanned a fairly broad age range, few data exist to 
support a large effect of age on the instestinal microbiota after age three (Yatsunenko et al., 
2012). Lastly, our analysis focused on taxonomic and diversity measures, which describes 
microbial composition but does not account for functional impact.
In examining composition and diversity of the intestinal microbiota in three patients 
undergoing treatment for AN, we found significant, patient-specific changes during hospital-
based renourishment. Even in a controlled environment, on a stringent refeeding protocol, 
with significant weight gain, and in a disease state marked by microbial dysbiosis, individual 
microbial signatures persisted in accounting for the majority of variation in microbial 
composition and diversity. Although all patients experienced peaks in hypermetabolism in 
treatment weeks 2–3, we were unable to detect specific associations between hypermetabolic 
state and the intestinal microbiota. Future work should aim to elucidate temporal changes to 
the intestinal microbiome during renourishment (and associated changes in metabolic 
activity), which will increase understanding of host-microbial dynamics during treatment 
and could help explain persistence of weight dysregulation and metabolic changes in 
recovered AN patients.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Intestinal microbiotas of three AN patients during renourishment
(A) BMI (kg/m2, blue) and energy intake (kJ/day, orange). (B) Taxonomic composition: 
abundance of specific genera exhibit variability during refeeding. (C) Microbial richness: 
number of observed OTUs in fecal samples varies during refeeding. (D) Principal coordinate 
analysis of unweighted UniFrac distances: samples cluster by patient [p =0.001, analysis of 
similarity (ANOSIM)], suggesting disease state or renourishment is not sufficient to 
overpower unique enteric microbiota composition harbored by each individual.
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Table 1
Demographic and clinical characteristics of patients
Patient A Patient B Patient C
Age (years) 25 29 16
Race Asian Caucasian Caucasian
BMI (kg/m2)
Admission 15.6 17.6 13.7
Discharge 20.2 21.1 15.4
Length of stay (days) 73 58 34
Number of fecal samples 68 47 33
Energy intake (kJ)
Admission 4186 5860 5860
Discharge 13395 13395 13395
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